JENNIE CARTER: Open Payments
NPI 1427423078 · JACKSBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 57 payments from 11 companies in 2025. Trend: 2023 $796 · 2024 $1,083 · 2025 $1,349
Food & beverage: $1,349
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $452 |
| AstraZeneca Pharmaceuticals LP | 8 | $244 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $192 |
| Sumitomo Pharma America, Inc. | 5 | $106 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| ABBVIE INC. | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: CAPLYTA, Kerendia, ENHERTU, GEMTESA, REXULTI, TRELEGY ELLIPTA, VRAYLAR, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
